Eric Johnston, Cantor Fitzgerald chief equity and macro strategist, joins 'Money Movers' to discuss Johnston's thesis for ...
We recently compiled a list of the 13 AI News and Ratings on Wall Street’s Radar. In this article, we are going to take a ...
Cantor Fitzgerald assumed coverage on shares of Voyager Therapeutics (NASDAQ:VYGR – Free Report) in a research note published on Friday morning, Marketbeat reports. The firm issued an overweight ...
Fintel reports that on January 10, 2025, Cantor Fitzgerald initiated coverage of Voyager Therapeutics (NasdaqGS:VYGR) with a ...
Cantor Fitzgerald initiated coverage on shares of Check Point Software Technologies (NASDAQ:CHKP – Free Report) in a research ...
We recently compiled a list of the 14 AI Stocks Making Waves on Wall Street. In this article, we are going to take a look at ...
Cantor Fitzgerald initiated coverage of Bright Minds Biosciences (DRUG) with an Overweight rating and no price target The company’s emerging ...
Cantor Fitzgerald assumed coverage of Zevra Therapeutics (ZVRA) with an Overweight rating and $25 price target Zevra is a rare disease, ...
Cantor Equity Partners I, Inc. (Nasdaq: CEPO) (the "Company") announced today that it closed its initial public offering ...
Cantor Equity Partners I, Inc. (Nasdaq: CEPO) (the "Company") announced today that it priced its initial public offering ...
Cambridge Nutritional Sciences PLC has announced that Cantor Fitzgerald Europe has crossed the 5% threshold in its voting rights, now holding 5.207% of the total voting rights. This acquisition of ...
Cantor Fitzgerald analyst Deepak Mathivanan downgraded Sabre (SABR) to Neutral from Overweight with a price target of $4, down from $5, after assuming coverage of the name. Cantor expects fiscal ...